Pages that link to "Q38480403"
Jump to navigation
Jump to search
The following pages link to Efficacy of Corticosteroid Therapy in Patients With an Acute Exacerbation of Chronic Obstructive Pulmonary Disease Receiving Ventilatory Support (Q38480403):
Displaying 27 items.
- Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease (Q24193908) (← links)
- Interventions for preventing critical illness polyneuropathy and critical illness myopathy (Q24200934) (← links)
- Systemic corticosteroids in acute exacerbation of COPD: a meta-analysis of controlled studies with emphasis on ICU patients (Q27010596) (← links)
- When should acute exacerbations of COPD be treated with systemic corticosteroids and antibiotics in primary care: a systematic review of current COPD guidelines (Q28085429) (← links)
- Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary (Q34550471) (← links)
- Associations between bolus infusion of hydrocortisone, glycemic variability and insulin infusion rate variability in critically Ill patients under moderate glycemic control. (Q36241197) (← links)
- Optimizing safety of COPD treatments: role of the nurse practitioner (Q36642198) (← links)
- Community-acquired pneumonia and survival of critically ill acute exacerbation of COPD patients in respiratory intensive care units (Q37175317) (← links)
- Pharmacological Management and Prevention Of Exacerbations of Chronic Obstructive Pulmonary Disease in Hospitalized Patients (Q37372207) (← links)
- The management of asthma and chronic obstructive pulmonary disease: current status and future perspectives (Q37979254) (← links)
- Gender differences in randomised, controlled trials in intensive care units (Q38211761) (← links)
- Acute exacerbations of chronic obstructive pulmonary disease: diagnosis, management, and prevention in critically ill patients. (Q38511557) (← links)
- The intensive care medicine research agenda for airways, invasive and noninvasive mechanical ventilation. (Q38645676) (← links)
- Glucocorticoid-induced hyperglycaemia in respiratory disease: a systematic review and meta-analysis (Q38890253) (← links)
- Single-Center Retrospective Evaluation of Inhaled Corticosteroid Use for Chronic Obstructive Pulmonary Disease Exacerbation Patients Receiving Systemic Corticosteroids. (Q39032379) (← links)
- A Survey of Corticosteroid Dosing for Exacerbations of Chronic Obstructive Pulmonary Disease Requiring Assisted Ventilation (Q40067048) (← links)
- Relationship of Steroid Dosing and Duration of Mechanical Ventilation in Adult Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease (Q40242815) (← links)
- Predicting In-Hospital Treatment Failure (≤ 7 days) in Patients with COPD Exacerbation Using Antibiotics and Systemic Steroids. (Q40448715) (← links)
- Protocol-based treatment of septic shock, fibrinolysis for submassive pulmonary embolism, and use of corticosteroids in acute exacerbations of chronic obstructive pulmonary disease requiring mechanical ventilation (Q41720473) (← links)
- Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease (Q45015016) (← links)
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary (Q47984024) (← links)
- [Diagnosis and therapy of COPD exacerbation]. (Q52888876) (← links)
- Comparison of efficiency of inhaled and intravenous corticosteroid on pregnant women with COPD and the effects on the expression of PCT and hs-CRP. (Q55292429) (← links)
- Management of severe acute exacerbations of COPD: an updated narrative review (Q57298307) (← links)
- Do Benefits Outweigh Risks for Corticosteroid Therapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease in People with Diabetes Mellitus? (Q90668963) (← links)
- Chronic Obstructive Pulmonary Disease: Inpatient Management (Q91912458) (← links)
- Efficacy and safety of Jia Wei Bushen Yiqi formulas as an adjunct therapy to systemic glucocorticoids on acute exacerbation of COPD: study protocol for a randomized, double-blinded, multi-center, placebo-controlled clinical trial (Q98944077) (← links)